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Background: Vibrio parahaemolyticus is a Gram-negative halophilic bacterium. Infections with the bacterium could
become systemic and can be life-threatening to immunocompromised individuals. Genome sequences of a few
clinical isolates of V. parahaemolyticus are currently available, but the genome dynamics across the species and
virulence potential of environmental strains on a genome-scale have not been described before.
Results: Here we present genome sequences of four V. parahaemolyticus clinical strains from stool samples of
patients and five environmental strains in Hong Kong. Phylogenomics analysis based on single nucleotide
polymorphisms revealed a clear distinction between the clinical and environmental isolates. A new gene cluster
belonging to the biofilm associated proteins of V. parahaemolyticus was found in clincial strains. In addition, a novel
small genomic island frequently found among clinical isolates was reported. A few environmental strains were
found harboring virulence genes and prophage elements, indicating their virulence potential. A unique biphenyl
degradation pathway was also reported. A database for V. parahaemolyticus (http://kwanlab.bio.cuhk.edu.hk/vp) was
constructed here as a platform to access and analyze genome sequences and annotations of the bacterium.
Conclusions: We have performed a comparative genomics analysis of clinical and environmental strains of
V. parahaemolyticus. Our analyses could facilitate understanding of the phylogenetic diversity and niche adaptation
of this bacterium.
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Foodborne diseases remain a serious public health prob-
lem worldwide. In Hong Kong, infections due to food-
borne pathogens are also a common and important public
health issue. Among all causative agents resulting in food-
borne outbreaks, bacteria have caused more than 80% of
the cases. In 2006, the Centre for Health Protection of
Hong Kong revealed more than 800 local foodborne out-
breaks due to bacterial causative agents, inflicting more
than 3000 people [1]. Vibrio parahaemolyticus, a Gram-* Correspondence: hoishankwan@cuhk.edu.hk
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unless otherwise stated.negative pathogenic halophilic bacterium, is the most
prevalent in certain Asian areas and causes food poisoning,
occasionally outbreaks, especially in the hot season [2].
V. parahaemolyticus is well known as the causative
agent of the most prevalent food poisoning in Asia since
the mackerel-borne outbreak in 1959 [3]. V. parahaemo-
lyticus infections arise from the consumption of raw or
undercooked seafood, typically causing gastroenteritis
[4]. Infections can become systemic and can be life-
threatening to immunocompromised individuals [5].
V. parahaemolyticus strains isolated from diarrheal
patients produce thermostable direct hemolysin (TDH),
TDH-related hemolysin (TRH), or both, while isolates
from the environment rarely contain genes encodingis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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V. parahaemolyticus and present in most of the clinical
Kanagawa phenonemon (KP)-positive strains. In addi-
tion to its hemolytic activity, enterotoxicity, cytotoxicity
as well as cardiotoxicity have been confirmed in TDH
[6]. TDH-related hemolysin (TRH) is produced by KP-
negative strains, encoded by trh gene, with about 67%
amino acid sequence homology and immunologically
related with TDH [7]. TRH is hemolytic, heat labile and
is suspected to play an unclarified role in the diarrhea
caused by these KP-negative strains. After the bacteria pro-
duce TDH and lipopolysaccharides released from a dead
cell, human host would show strong systemic responses
and produce mucosal B-cells against these antigens. How-
ever, recent study has also revealed that V. parahaemolyti-
cus could profoundly disturb epithelial barrier function in
Caco-2 cells with other virulence factors, in the absence of
TDH [8]. V. parahaemolyticus also encodes two type III
secretion systems (T3SS), which are located in different
chromosomes. The contribution of these two T3SS has
previously been characterized in animal models [9,10].
These two T3SSs are involved in distinct pathogenic me-
chanisms during infection. The type III secretion system 1
(T3SS1) is required for cytotoxicity, whereas the type III
secretion system 2 (T3SS2) is often responsible for entero-
toxicity and intestinal fluid accumulation. The overall
mechanism of pathogenesis in V. parahaemolyticus remains
unclear.
V. parahaemolyticus infections are associated with
multiple serotypes. Analysis of an outbreak in Calcutta in
1996 has identified a unique serotype clone, O3:K6, which
is not previously isolated in that area [11]. After thisTable 1 List of V. parahaemolyticus clinical and environmenta
Strain Specimen collection date Source
VIP4-0395 20/11/07 Local-Stool
VIP4-0439 10/09/08 Local-Stool
VIP4-0445 26/09/08 Local-Stool
VIP4-0407 18/01/08 Local-Stool
AQ3810 1983 Singapore
AQ4037 1985 Maldives
RIMD2210633 1996 Thailand
Peru-466 1996 Peru
AN-5034 1998 Banglandesh
K5030 2005 India
VIP4-0430 03/07/08 Local-Oyster
VIP4-0443 23/09/08 Local-Big eye fish
VIP4-0219 13/04/06 Local-Salmon Sashim
VIP4-0444 23/09/08 Local-Big eye fish
VIP4-0447 22/10/08 Local-Oyster
UT: Untypeable.report, O3:K6 isolates and its serovariants, defined to have
identical genotype and molecular characteristics to those
isolated in Calcutta, have been reported from foodborne
outbreaks across the world. These serotypes were thought
to be clonal derivatives of the O3:K6 serotype [12]. Recent
multilocus sequence typing (MLST) data have further
confirmed that multiple serotypes occur in a single genetic
lineage [13].
Comparative genomics analysis of merely clinical strains
of V. parahaemolyticus was described before [14]. How-
ever, the phylogenetic diversity and niche adaptation of
V. parahaemolyticus at the species level is currently
unknown. Strains isolated from environmental reservoirs
could be as virulent as clinical strains in animal models
[15], and the existing regulatory mechanisms of environ-
mental V. parahaemolyticus could favor regulations of
foreign virulence genes [16]. Nonetheless, the virulence
potential of V. parahaemolyticus at the genome-wide level
has not been described before. We sequenced the ge-
nomes of four O3:K6 and its serovariant clinical strains
and five environmental strains of V. parahaemolyticus in
Hong Kong. Genomes of a few environmental V. parahae-
molyticus isolates have been announced recently [17-20],
however, comparative genomics study has not been
reported until now. Phylogenomic analysis of our local
strains and other available genomes revealed a clear
distinction between clinical and environmental strains.
Results and discussion
Summary of genome sequencing data
As summarized in Table 1, we have completed 454 ge-
nome sequencing of nine V. parahaemolyticus isolatesl isolates analyzed in this study
tdh trh Serotype CDS Reference
+ - O3:K6 4711 This study
+ - O3:K6 4733 This study
+ - O3:K6 6226 This study
+ - O3:K59 4692 This study
+ - O3:K6 5458 [11]
- + O3:K6 4447 [9]
+ - O3:K6 4831 [12]
+ - O3:K6 4603 [9]
+ - O4:K68 4770 [9]
+ - O3:K6 4606 [9]
- - O4:K34 5698 This study
- - O2:UT 5994 This study
i - - O1:UT 4761 This study
- - O11:UT 4976 This study
- - O6:UT 5091 This study
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environmental strains. The average sequencing coverage
was between 44× to 66×. Genome sequences of these
local V. parahaemolyticus strains were de novo assem-
bled using Newbler 2.7 (Roche Diagnostics). Genome
assembly of V. parahaemolyticus yielded 130 to 1205
contigs of N50 contig length ranging from 7 kb to 305
kb. The clinical strains we sequenced were new O3:K6
and its serovariant (O3:K59), and they were positive for
the tdh gene but negative for the trh gene. Our environ-
mental strains were all tdh and trh negative. We have
also included in our analyses six publicly available V.
parahaemolyticus genomes, which are all clinical strains
(Table 1) and two of them (AQ3810, AQ4037) pre-pandemic
strains [14].Phylogenetic relationships
Phylogenetic relationships among our V. parahaemolyti-
cus isolates and the reference strains (Table 1) were exa-
mined using a genome-wide approach based on 169,998
single nucleotide polymorphisms (SNPs). Eighty nine per-
cent of these SNPs were in coding regions, of which 25.8%
were missense, 0.6% was nonsense, and 73.6% were syn-
onymous. Genome-wide comparison readily resolved the
relationship among the clinical and environmental isolates
(Figure 1). Clinical strains were found to be more rela-
ted compared to the environmental strains. Moreover,
our local clinical isolates were highly similar to RIMD
2210633 isolated from Thailand in 1996, consistent with
previous results using various molecular methods [21] AQ4037
 K5030
 AN-5034
 Peru-466
 VIP4-0439 (local)
 VIP4-0445 (local)
 VIP4-0395 (local)
 VIP4-0407 (local)
 RIMD 2210633
 AQ3810
 VIP4-0443 (local)
 VIP4-0430 (local)
 VIP4-0219 (local)
 VIP4-0444 (local)
 VIP4-0447 (local)
100
98
70
93
97
100
100
100
67
100
100
0.002
Figure 1 Neighbor-joining phylogenetic tree showing
relationships among V. parahaemolyticus isolates inferred
using SNP sites. Nodal supports were calculated from 500 bootstrap
pseudoreplicates. The tree was rooted using Vibrio harveyi ATCC
BAA-1116. The scale bar represents 0.002 substitutions per nucleotide
position. Red color indicates clinical strains, and grey color indicates
environmental strains.[22] and further confirm clonality of new O3:K6 and its
serovariants.
Pan-genome analysis
Comparative analysis of nine newly sequenced genomes
and six publicly available genomes of V. parahaemolyticus
could help us determine the global gene repertoire of the
species. This can be described by its ‘pan-genome’ that
includes a core genome containing genes present in all
strains and a dispensable genome composed of genes ab-
sent from one or more strains and genes that are unique
to some strains. Here, the core and pan-genomes of V.
parahaemolyticus were identified using OrthoMCL [23].
Our result shows that the number of pan-genome
gene families increased with the number of genomes
analysed, indicating that V. parahaemolyticus harbors an
open pan-genome (Figure 2). We have also analyzed the
trend of new gene families, and we found that new genes
will continue to be found with increasing of much more
genomes.
Gene-content analysis of V. parahaemolyticus
By investigating the presence and absence of genes in V.
parahaemolyticus, we found that most regions within
their genomes were conserved (Figure 3). We then
further analyzed 24 genomic regions that are unique to
V. parahaemolyticus RIMD 2210633 [24], which mainly
include two T3SS, seven pathogenic islands, and f237
prophages. Comparative genomics revealed that these 24
regions accounted for most of the varying regions. Five
pathogenic islands (VPal-1, VPal-3, VPal-4, VPal-5, and
VPal-6) were found absent in not only the environmen-
tal strains, but also two pre-pandemic clinical strains.
VPal-7 was found absent in AQ4037 and other environ-
mental strains.
Previously, microarray-based approach failed to detect
genes responsible for pathogenesis of V. parahaemolyti-
cus [25]. Traditional features also failed to differentiate
clinical strains from environmental strains [26,27]. Here,
analysis of these varying regions revealed the presence of
only 11 regions in the clinical group, which were absent
in the environmental group (Table 2). As expected,
genes in T3SS2 were not found in all of the clinical
strains, which further confirm that it is not reliable to
simply use tdh, trh or genes in T3SS as virulence
features [25]. However, a region located in chromosome
II (984909–999901) contained genes from VPA0950 to
VPA0957, which encode putative biofilm associated pro-
teins and outer membrane proteins. A few genes inclu-
ding two type IV pili were previously described in
biofilm formation of V. parahaemolyticus, however de-
tails of the process are still unexplored in this bacterium
[28,29]. In other Vibrio species such as V. fischeri, bio-
film formation was found to play an important role in
Figure 2 Gene repertoire analysis of V. parahaemolyticus. (A) Pan-genome and core genome size accumulation. (B) New gene family accumulation.
The green bars indicate the number of expected new gene family detected for a particular number of genomes analysed, and the orange line indicates
the trend of expected new gene family with an increasing number of genomes.
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found in clinical strains of V. parahaemolyticus could
also provide this bacterium with advantages in host
adaptation. These gene clusters have not been found
previously, and we suggest that they could act as new
candidate virulence markers.
A novel genomic island commonly found in clinical
strains
O3:K59 is a new serovariant of serotype O3:K6. It is
recently reported that it could replace local serovariants
and has caused pandemics in Chile and Peru [31,32].Here we analyzed the genome of our O3:K59 strain
VIP4-0407 and found a novel genomic island that is
absent in V. parahaemolyticus RIMD 2210633 [33]. This
genomic island was found in most of our clinical strains
including AQ4037, K5030, AN-5034, Peru-466, VIP4-
0439, VIP4-0395, VIP4-0407 and AQ3810, but was absent
in our environmental strains. We defined this genomic
island as Vibrio parahaemolyticus island-8 (VPal-8). It
contained six CDSs (Table 3), one of which showing high
similarity with an AraC family transcriptional regulator
that caused virulence in a mouse infection model in Myco-
bacterium tuberculosis [34]. ArcC family transcriptional
Figure 3 BRIG visualization of V. parahaemolyticus genomes. The innermost circles represent the reference sequence of V. parahaemolyticus
2210633. Outer rings illustrate shared identity with other V. parahaemolyticus isolates.
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rial virulence [35], We analyzed sequences in this genomic
island to determine whether there is any T3SS secreted
protein. Using a combination of available T3SS prediction
tools including T3_MM [36], Effective T4 [37], and T3SS
effector prediction [38], we found that the third protein inthis genomic island showed positive results in all of the
prediction tools.
We further investigated whether VPal-8 is widespread
across the population of clinical strains. Using this
genomic island as a probe to perform southern hy-
bridization on an additional population of 40 clinical
Table 2 Genomic regions that found in clinical group only
Reference No. Chr Start End Length Features in this regions* Descriptions
NC_004603.1 Chr1 1630527 1631678 1151 VP1517, VP1518 Rhs-family protein
NC_004603.1 Chr1 1632125 1632898 773 VP1520, VP1521 Hypothetical protein
NC_004605.1 Chr2 433304 434859 1555 VPA0442,VPA0443 Hypothetical protein
NC_004605.1 Chr2 436019 437350 1331 VPA0445, VPA0446 Methylamine utilization protein MauG precursor
NC_004605.1 Chr2 438755 439983 1228 VPA0447 Hypothetical protein
NC_004605.1 Chr2 823596 824400 804 VPA0796 L-allo-threonine aldolase
NC_004605.1 Chr2 984909 986361 1452 VPA0950, VPA0951 Hypothetical protein
NC_004605.1 Chr2 987912 990219 2307 VPA0952, VPA0953(partial) Biofilm-associated surface protein
NC_004605.1 Chr2 994472 995346 874 VPA0953 (partial) Biofilm-associated surface protein
NC_004605.1 Chr2 995407 998918 3511 VPA0954, VPA0955, VPA0956, VPA0957 (partial) Agglutination protein,outer membrane protein
NC_004605.1 Chr2 998994 999901 907 VPA0957 (partial) Transporter binding protein
*The gene name is based on annotation of Vibrio parahaemolyticus RIMD 2210633.
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found in 29 of the clinical strains (Additional file 1:
Table S1). Therefore, we suggest that the genomic island
found in this study may be related to the virulence of V.
parahaemolyticus.
sRNAs and CRISPR element analysis
CRISPRs (Clustered regularly interspaced short palin-
dromic repeats) could play important roles in the in-
teraction of bacteria and mobile genetic elements [39].
We annotated CRISPR elements in V. parahaemolyticus
using CRISPR finder [40] and found a total of six
CRISPR elements (Table 4). Our environmental strains
were found to harbor fewer CRISPR types, whereas at
least two CRISPRs were found in each of the clinical
strains.
sRNAs are a class of non-coding RNAs in bacteria and
are important post-transcriptional regulators in multiple
crucial biological processes such as biofilm formation,
quorum sensing and virulence [41,42] . We determined
the sRNA sequences in our V. parahaemolyticus strains
and found that most sRNAs were highly conserved
(Additional file 2: Table S2). However, a few sRNAs such
as GcvB and STnc1460 were only present in a few
strains, indicating that these sRNAs may mediate some
strain-specific regulations.Table 3 Gene clusters in small genomic island found in V. par
No. Accession ID Start End No. of aa* Homolog accession
1 AXNM01000034 96777 97262 162 NP_797023.1
2 AXNM01000034 97884 99086 401 ZP_05776346.1
3 AXNM01000034 99645 100427 261 ZP_05888734.2
4 AXNM01000034 100420 101163 248 WP_025628220.1
5 AXNM01000034 102145 101300 282 ZP_01990379.1
6 AXNM01000034 103426 104361 312 ZP_01990406.1
*Amino acids.Biphenyl degradation pathway identified in
environmental strains
We annotated the subsystems of V. parahaemolyticus
genomes using the RAST Server [43] (Figure 4). Five
subsystems were found enriched in the environmental
strains, including Metabolism of Aromatic Compounds
(p = 1.12E06), Protein metabolism (p = 0.01), Iron acqui-
sition and metabolism (p = 0.027), Phages and Prophages
(p = 0.041) and Sulfur Metabolism (p = 0.046). The most
enriched subsystem “Metabolism of Aromatic Compounds”
contained an average of six genes in clinical strains, but an
average of 10 genes in the environmental strains.
We further examined this category to investigate
which pathway has contributed most of the differences.
Genes involved in biphenyl degradation pathway (BphE1,
BphC, Bphj2) were found in all of our environmental
strains but not in the clinical strains, except the pre-
pandemic strain AQ3810 (Table 5). The presence of the
unique biphenyl degradation pathway in our environ-
mental strains is possibly caused by the widespread of
polychlorinated biphenyls in the environment [44].
Virulence potential of environmental strains
V. parahaemolyticus harbors many virulence factors in-
cluding TDH, TRH and two T3SSs, which are generally
pathogenic. Here we report the distribution of virulenceahaemolyticus
no. Description
SsrA-binding protein
Phage integrase family protein
Putative cyclic diguanylate phosphodiesterase (EAL) domain protein
AraC family transcriptional regulator
Hypothetical protein
Hypothetical protein
Table 4 Distribution of CRISPRs in V. parahaemolyticus strains
Strain Source CRISPR 1 CRISPR 2 CRISPR 3 CRISPR 4 CRISPR 5 CRISPR 6
RIMD 2210633 Clinical + - + - - -
AQ3810 Clinical - + + - - +
Peru 466 Clinical + + - - - -
K5030 Clinical + - + - - -
AQ4037 Clinical - - + - + -
AN-5034 Clinical + - + - - -
VIP4-0439 Clinical + - + + - -
VIP4-0395 Clinical + - + - - -
VIP4-0407 Clinical + + - - - -
VIP4-0445 Clinical + + - - - -
VIP4-0444 Environmental - + - - + -
VIP4-0219 Environmental - - + - - -
VIP4-0447 Environmental - - - - - -
VIP4-0430 Environmental - - - - - -
VIP4-0443 Environmental - - - - - -
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haemolyticus strains to reveal their pathogenic potential.
We predicted prophage regions in V. parahaemolyticus
using the PHAST webserver [45] and found that clinical
strains were restricted to a few prophage elements. The
pandemic group of clinical strains possessed a filamentous
prophage f237, which could increase virulence by adhering
to intestinal cells [46]. A similar prophage was also found
in the AQ3047 strain. In contrast, many diverse pro-
phage elements were found in our environmental strainsSu
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Figure 4 Subsystem annotation of V. parahaemolyticus. The y-axis repr
shows the respective -log(P) values. P-values were calculated to examine if
of environmental strains and clinical strains. The subsystem “metabolism of
(P-value <0.05, −logP >1.3).(Table 6). Six new prophages were found in four of our
environmental strains, which harbor genes that could en-
hance the fitness for survival in specific environments. We
further examined the relationship between the number of
prophages and CRISPR in our strains. We analyzed the
spacer sequences of CRISPRs and eight unique spacers se-
quence were found. However, we could not find any hom-
ologous prophage regions that could match with these
spacer sequences in the respective strains. This could be
explained by the possibility that the CRISPRs of Vibrio-log(Pvalue) 
2 3 4 5 6
esents subsystems annotated in the RAST server whereas the x-axis
there is significant difference in the numbers between the subsystems
aromatic compounds” was shown to have a most significant P-value
Table 5 Detection of biphenyl degradation pathway
genes
Strains* Source BphE1 BphC Bphj2
VIP4-0444 Environmental + + +
VIP4-0219 Environmental + + +
VIP4-0430 Environmental + + +
VIP4-0443 Environmental + + +
VIP4-0447 Environmental + + +
AQ3810 Clinical + + +
*Only strains with positive results are shown here.
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the host genome. Indeed, an inverse correlation of
CRISPRs with the number of prophage was also described
in Streptococcus pyogenes [47].
toxR gene, located next to toxS gene, involves in the
regulation of many virulence-associated genes of V. para-
haemolyticus [48]. Variation in the toxR sequence can be
used to differentiate phylogenetically distinct clusters in V.
parahaemolyticus. Seven base positions were previously
identified to distinguish the O3:K6 isolates before 1995
from the new O3:K6 clones within a 1346-bp region [49].
We further investigated the variations between these base
positions within our V. parahaemolyticus isolates. In all of
the seven new O3:K6 clones, the bases were perfectly
mapped to the reference ones (Table 7). However, another
environmental strain (VIP4-0443) also had the same se-
quence bases with the new O3:K6 clones, suggesting that
it may also harbor virulence potential. We then further
examined whether there are any other virulence proteins
in this strain. A total of 264 candidate virulence genes
were found (Additional file 3: Table S3), which further
confirm that this environmental strain could have viru-
lence potential.
Construction of a genome sequence database for
V. parahaemolyticus
A V. parahaemolyticus genome database was constructed
here based on the Ensembl genome annotation system
using Perl scripts (Figure 5). Genome DNA sequences can
be input into the platform via a user-friendly web-based
interface. Our web-based database allows comparative
analysis and data mining using available V. parahaemolyti-
cus genome data. A suite of useful computational tools is
now available for data analysis such as MLST and detec-
tion of genetic variations. The web-based database is now
launched as a publicly accessible domain (http://kwanlab.
bio.cuhk.edu.hk/vp).
Conclusions
This is the first study on the genome dynamics of V. para-
haemolyticus at the species level. We have three main
conclusions. First, by comparing the genome sequences,we found that our clinical strains were phylogenetically
distinct from the environmental strains. We discovered a
new gene cluster belonging to the biofilm associated pro-
teins of V. parahaemolyticus. We suggest that this novel
gene cluster is a new virulence marker differentiating
clinical from environmental strains. We also found a novel
genomic island (VPal-8) that frequently distributed in the
clincial strains. Second, by analyzing the virulence features
and prophage elements of our environmental strains on a
genome-wide scale, we discovered a new type of toxRS in
one of the environmental strains and a diverse array of
prophage elements in the environmental strains. These re-
sults indicate that the environmental strains studied could
have virulence potential. Third, we set up an Ensembl-
based genome database for V. parahaemolyticus to pro-
vide a unified and user-friendly platform to access all
currently available genome sequences and annotations of
this bacterium.
Methods
Ethics statement and isolate collection
Nine isolates of V. parahaemolyticus were selected from
the bacterial archive maintained at the microbiology
laboratory of the Department of Health of Hong Kong
and were characterized for genome sequencing. The study
was approved by the Joint CUHK-NTEC Clinical Research
Ethical Committee at the Prince of Wales Hospital in
Hong Kong. Written informed consent was obtained from
all the studied subjects for sample collection and subse-
quent analysis.
DNA sequencing
Whole-genome shotgun sequencing was performed using
a 454 Genome Sequencer (GS) FLX-Titanium (Roche
Diagnostics, US). DNA of each selected isolate was
extracted from culture and subjected to sequencing library
preparation according to the manufacturer’s recommen-
ded protocols. Libraries of processed genomic DNA
fragments immobilized on DNA capture beads were indi-
vidually sequenced on a PicoTiterPlate device. Bases se-
quenced and the corresponding quality values were called
and delivered in a standard format by GS-FLX-Titanium
system for downstream bioinformatic analyses. The
remaining genome gaps were filled by the GS-FLX-
provided paired-end approach and/or primer walking.
The primer walking approach involved design of primers
flanking the gaps and PCR to amplify the DNA fragments
covering the gaps. PCR products were then directly
sequenced using the ABI DNA Sequencer (Applied
Biosystems, US).
Sequence assembly and annotation
Raw sequence reads were first filtered to remove low-
quality reads. Sequence assembly was performed on the
Table 6 Distribution of prophages in V. parahaemolyticus strains
Strains* Source Prophage 1 (f237) Prophage 2 (f237-like) Prophage 3 Prophage 4 Prophage 5 Prophage 6 Prophage 7 Prophage 8
RIMD 2210633 Clinical +
Peru 466 Clinical +
K5030 Clinical +
AN-5034 Clinical +
VIP4-0439 Clinical +
VIP4-0395 Clinical +
VIP4-0407 Clinical +
VIP4-0445 Clinical +
AQ4037 Clinical - +
VIP4-0444 Environmental - 19312/19312 8265/8265
VIP4-0447 Environmental - 12018/19312 6500/8265 91629/91629
VIP4-0219 Environmental - 34088/34088
VIP4-0430 Environmental - 58355/58355 48569/48569
*VIP4-0443,AQ3810 was excluded because no prophage was found in this strain. Numbers denote the length of homolog sequences / the length of intact prophage.
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Figure 5 Architecture of the Ensembl-based genome database for V. parahaemolyticus.
Table 7 Base variations in the toxRS sequence of selected V. parahaemolyticus strains
Strains Sources Position at the toxRS sequences
576 900 1002 1196 1214 1244 1463
RIMD 2210633 Clinical A A T T T A T
Peru 466 Clinical A A T T T A T
K5030 Clinical A A T T T A T
AN-5034 Clinical A A T T T A T
VIP4-0439 Clinical A A T T T A T
VIP4-0395 Clinical A A T T T A T
VIP4-0407 Clinical A A T T T A T
VIP4-0445 Clinical A A T T T A T
AQ4037 Clinical G G C C A G A
AQ3810 Clinical G G C C A G A
VIP4-0444 Environmental G G C C A G A
VIP4-0447 Environmental G G C C A G A
VIP4-0219 Environmental G G C C A G A
VIP4-0430 Environmental G G C C A G A
VIP4-0443 Environmental A A T T T A T
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http://www.biomedcentral.com/1471-2164/15/1135remaining clean reads de novo using the GS Newbler 2.7.
The genome sequences were annotated using the RAST
webserver. Contigs were reordered and genome compari-
sons were carried out using mauve program [50]. BRIG
was used for genome alignment visualization [51]. Pro-
phage elements of V. parahaemolyticus were predicted
using PHAST [45].
Phylogenetic tree construction
SNPs among our isolates and several foreign strains were
identified using GS Reference Mapper (Roche Diagnos-
tics). SNPs detected among all strains were concatenated
together and a neighbor-joining phylogenetic tree was
constructed using MEGA 6 [52] with 500 bootstrap
pseudoreplicates. Vibrio harveyi ATCC BAA-1116 was
used as outgroup for defining the root.
Small RNAs and CRISPRs
A list of small RNA sequences was retrieved from the
BSRD database [42]. sRNA homologs in our V. parahae-
molyticus isolates were then identified using BLASTn.
The e-value of BLAST was set to 1e-5. Annotation of
CRISPR elements was done using CRISPRfinder [40].
Experimental validation of genomic island
Two sets of primers were designed for PCR-based
detection of genomic island in a population of clinical V.
parahaemolyticus. These clinical strains were previously
used for microarray-based analysis [53].
Availability of supporting data
Data of this Whole Genome Shotgun project have been de-
posited at GenBank under the accessions AXNJ00000000,
AXNK00000000, AXNL00000000, AXNM00000000, AXN
O00000000, AXNP00000000, AXNQ00000000, AXNR00
000000, and AXNS00000000. The phylogenetic tree and
associated data matrix are available in TreeBASE database
(Accession URL: http://purl.org/phylo/treebase/phylows/
study/TB2:S16780).
Additional files
Additional file 1: Table S1. Primers used in PCR detection of genomic
island in V. parahaemolyticus isolates.
Additional file 2: Table S2: Distribution of sRNA sequences in V.
parahaemolyticus strains.
Additional file 3: Table S3. Homologous virulence-associated genes in
environmental strain VIP4-0443.
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